School of Medicine
Showing 6,271-6,280 of 12,989 Results
-
Ramrada Lekwuttikarn MD
Clinical Instructor, Dermatology
BioRamrada Lekwuttikarn, MD is a pediatric dermatologist and clinical investigator in the Division of Pediatric Dermatology at Stanford University School of Medicine and Lucile Packard Children’s Hospital. She serves as a Research Scientist and Clinical Instructor with expertise in vascular anomalies, genetic skin diseases, and inflammatory skin disorders.
Dr. Lekwuttikarn received her medical degree and pediatric training at Ramathibodi Hospital, Mahidol University, Thailand, and completed subspecialty training in pediatric dermatology at King Chulalongkorn Memorial Hospital in Thailand. She subsequently completed clinical research fellowships at the Children’s Hospital of Philadelphia and Stanford University. Prior to joining Stanford, she served as Chief of Pediatric Dermatology and Assistant Professor at Ramathibodi Hospital.
Her work focuses on translational research and clinical trials developing targeted therapies for complex pediatric skin diseases. -
Anna Lembke, MD
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)
BioDr. Anna Lembke received her undergraduate degree in Humanities from Yale University and her medical degree from Stanford University. She is currently Professor and Medical Director of Addiction Medicine, Stanford University School of Medicine. She is also Program Director of the Stanford Addiction Medicine Fellowship, Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic, and a diplomate of the American Board of Psychiatry and Neurology and the American Board of Addiction Medicine.
In 2016, she published "Drug Dealer, MD – How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop" (Johns Hopkins University Press, 2016), highlighted in the New York Times as one of the top five books to read to understand the opioid epidemic (Zuger, 2018).
Dr. Lembke appeared in the Netflix documentary The Social Dilemma, an unvarnished look at the impact of social media on our lives.
Her latest book, "Dopamine Nation: Finding Balance in the Age of Indulgence" (Dutton/Penguin Random House, August 2021) was an instant New York Times and Los Angeles Times bestseller and has been translated into 30 languages. It combines the neuroscience of addiction with the wisdom of recovery to explore the problem of compulsive overconsumption in a dopamine-overloaded world. -
Hendrikus Lemmens
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD)
Current Research and Scholarly InterestsClinical Pharmacology of Anesthetics
Morbid Obesity
Impedance Cardiography -
Jody Leng
Clinical Associate Professor (Affiliated), Multispecialty Anesthesiology
Staff, Multispecialty AnesthesiologyBioDr. Leng is a board-certified anesthesiologist, specializing in regional anesthesiology. She attended medical school at the University of Miami, and completed her anesthesiology residency and Regional Anesthesiology and Acute Pain Medicine (RAAPM) fellowship at Stanford Health Care. Prior to her medical career, she worked as an R&D engineer at a biomedical device startup in Silicon Valley. She currently serves as the Director of RAAPM at the VA in Palo Alto, the Program Director of the RAAPM fellowship, and the Co-Director of the Peer Support and Resiliency in Medicine (PRIME) wellness program at Stanford.
-
Theodore Leng, MD, MS, FACS
Professor of Ophthalmology (Ophthalmology Research/Clinical Trials) and, by courtesy, of Anesthesiology, Perioperative and Pain Medicine (MSD)
Current Research and Scholarly InterestsDr. Leng was the first surgeon in California to perform a subretinal transplant of adult neural stem cells into patients with macular degeneration and is actively researching cell and gene regenerative therapies for macular degeneration, retinitis pigmentosa, Stargardt disease, and other degenerative conditions of the macula and retina. He also has an active program in imaging informatics, oculomics, and deep learning to identify patients who are at risk for eye and systemic disease. The end goal is earlier detection and rapid treatment to maximize outcomes.
